Biologics contract service provider Abzena has launched a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture at its site in Cambridge, UK.   According to the company, the new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability a...